Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD,

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Stephen R. Broderick, MD, MPHS

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Is individualized mitral valve repair in the future?

Off-pump coronary artery bypass grafting does not preserve renal function better than on-pump coronary artery bypass grafting: Results of a case-matched.

Endoscopic Robotic Mitral Valve Surgery

Surgical approach to repair of ruptured chordae tendineae causing tricuspid regurgitation Vincent Chan, MD, Dominique Grisoli, MD, Marc Ruel, MD, MPH,

Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: Up to 21 years of clinical and echocardiographic results

Building a bioartificial heart: A 3-song saga

Pulmonary hypertension in valve disease: A beast of the past?

Intrinsic cardiac stem cells are essential for regeneration

Marc R. Moon, MD The Journal of Thoracic and Cardiovascular Surgery

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Hassane Abdallah, MD, Alaae Boutayeb, MD, Gebrine El Khoury, PhD

It is still mostly about the mitral valve

How should we treat air leaks?

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

The lord of the rings Antonio Miceli, MD, PhD

Alexandra Lamari-Fisher, PhD, Carlos M. Mery, MD, MPH

Is individualized mitral valve repair in the future?

Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures Tirone.

The unintended consequences in clinical research

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines Javier G. Castillo, MD, Anelechi.

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Clinical evaluation of functional mitral stenosis after mitral valve repair for degenerative disease: Potential affect on surgical strategy Thierry G.

Do we need a bibliometrician to know which way the wind is blowing?

Intermediate results of isolated mitral valve replacement with a Biocor porcine valve Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD,

Use of bilateral internal thoracic artery during coronary artery bypass graft surgery in Canada: The bilateral internal thoracic artery survey Stefano.

Stephen R. Broderick, MD, MPHS

Open thoracoabdominal aortic repair for chronic type B dissection

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Is commissural closure associated with mitral annuloplasty a durable technique for the treatment of mitral regurgitation? A long-term (≤15 years) clinical.

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Attachment disorder in thoracoabdominal surgery

Manuel J. Antunes, MD, PhD, DSc

Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitation

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Warfarin or aspirin after mitral valve repair: Why work harder?

Long-term outcomes of artificial chordal replacement with tourniquet technique in mitral valve repair: A single-center experience of 700 cases Minoru.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Surgical repair of congenital mitral valve malformations in infancy and childhood: A single-center 36-year experience Giovanni Stellin, MD, Massimo A.

Another case of underprovision of mitral valve repair surgery: Lessons from the Veterans Affairs health system Anelechi C. Anyanwu, MD, David H. Adams,

The continuing challenge of congenital heart disease in China

Commentary: Have mitral valve simulators made it to reality?

Clinical outcomes and fate of the distal aorta following 1-stage repair of extensive chronic thoracic aortic dissection Nicholas T. Kouchoukos, MD, Alexander.

“The more things change…”: The challenges ahead

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Francesco Nappi, MD, Cristiano Spadaccio, MD, PhD

Preoperative PFTs: The answer is blowing in the wind

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

How do we follow up our patients

Thanos Sioris, MD, Tirone E

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Sophia Chaudry, MD, Stephane Lambert, MD, Thierry G. Mesana, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 4, Pages S8-S11 (April 2012) DOI: 10.1016/j.jtcvs.2012.01.046 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Outcomes after mitral valve repair of myxomatous bileaflet prolapse. Overall survival, freedom from recurrent MR (≥2+), and freedom from mitral valve reoperation shown. At follow-up, 6 patients died, 4 patients had recurrent MR (≥2+), and 2 patients underwent mitral valve reoperation. The mean clinical follow-up interval was 3.0 ± 2.1 years, and the mean echocardiographic follow-up interval was 2.6 ± 2.1 years. The Journal of Thoracic and Cardiovascular Surgery 2012 143, S8-S11DOI: (10.1016/j.jtcvs.2012.01.046) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions